Private Capital Group’s Acorda Therapeutics ACOR Stock Holding History

Private Capital Group’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	–	–	2169
2022 Q1	$0	Hold	1	–	–	﹤0.01%	2237
2021 Q4	$0	Buy	+1	New	+$69	﹤0.01%	2219
2021 Q2	–	Sell	-1	Closed	–	–	2196
2021 Q1	$0	Hold	1	–	–	﹤0.01%	2206
2020 Q4	$0	Hold	1	–	–	﹤0.01%	2157
2020 Q3	$0	Hold	1	–	–	﹤0.01%	2146
2020 Q2	$0	Hold	1	–	–	﹤0.01%	2180
2020 Q1	$0	Hold	1	–	–	﹤0.01%	2191
2019 Q4	$0	Hold	1	–	–	﹤0.01%	2241
2019 Q3	$0	Hold	1	–	–	﹤0.01%	2498
2019 Q2	$3K	Hold	1	–	–	﹤0.01%	1843
2019 Q1	$1K	Hold	1	–	–	﹤0.01%	2121
2018 Q4	$1K	Hold	1	–	–	﹤0.01%	2129
2018 Q3	$1K	Hold	1	–	–	﹤0.01%	2123
2018 Q2	$3K	Hold	1	–	–	﹤0.01%	1835
2018 Q1	$1K	Sell	1 -5	-83%	-$15K	﹤0.01%	2053
2017 Q4	$1K	Buy	+6	New	+$17.1K	﹤0.01%	1996

Other funds holding ACOR

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

CCA

Canyon Capital Advisors Dallas, Texas $882M AUM 62.77% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Saltoro Capital Dallas, Texas $30K AUM 24.79% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Private Capital Group's ACOR Position: Q2 2022 in Review

Private Capital Group sold out of Acorda Therapeutics (ACOR) in Q2 2022, closing a stake of 1 share.

Private Capital Group first reported a position in ACOR in Q4 2017 and held it in 16 quarters. The position peaked at $3K in Q2 2019. 32 funds tracked by Wall St. Rank hold ACOR as of Q2 2022.

Private Capital Group reported no remaining Acorda Therapeutics position as of Q2 2022 after selling out during the quarter.
Private Capital Group sold 1 Acorda Therapeutics share in Q2 2022.
Private Capital Group first reported a position in Acorda Therapeutics in Q4 2017 and held it in 16 quarters.
Private Capital Group's Acorda Therapeutics position peaked at $3K in Q2 2019.
32 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.